These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

593 related articles for article (PubMed ID: 18054440)

  • 21. Non-HFE hemochromatosis.
    Pietrangelo A
    Semin Liver Dis; 2005 Nov; 25(4):450-60. PubMed ID: 16315138
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New insights into the regulation of iron homeostasis.
    Deicher R; Hörl WH
    Eur J Clin Invest; 2006 May; 36(5):301-9. PubMed ID: 16634833
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hfe and Hjv exhibit overlapping functions for iron signaling to hepcidin.
    Kent P; Wilkinson N; Constante M; Fillebeen C; Gkouvatsos K; Wagner J; Buffler M; Becker C; Schümann K; Santos MM; Pantopoulos K
    J Mol Med (Berl); 2015 May; 93(5):489-98. PubMed ID: 25609138
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Iron overload in adult Hfe-deficient mice independent of changes in the steady-state expression of the duodenal iron transporters DMT1 and Ireg1/ferroportin.
    Herrmann T; Muckenthaler M; van der Hoeven F; Brennan K; Gehrke SG; Hubert N; Sergi C; Gröne HJ; Kaiser I; Gosch I; Volkmann M; Riedel HD; Hentze MW; Stewart AF; Stremmel W
    J Mol Med (Berl); 2004 Jan; 82(1):39-48. PubMed ID: 14618243
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-HFE haemochromatosis.
    Wallace DF; Subramaniam VN
    World J Gastroenterol; 2007 Sep; 13(35):4690-8. PubMed ID: 17729390
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of new mutations of the HFE, hepcidin, and transferrin receptor 2 genes by denaturing HPLC analysis of individuals with biochemical indications of iron overload.
    Biasiotto G; Belloli S; Ruggeri G; Zanella I; Gerardi G; Corrado M; Gobbi E; Albertini A; Arosio P
    Clin Chem; 2003 Dec; 49(12):1981-8. PubMed ID: 14633868
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pathophysiology and genetics of classic HFE (type 1) hemochromatosis].
    Loréal O; Ropert M; Mosser A; Déhais V; Deugnier Y; David V; Brissot P; Jouanolle AM
    Presse Med; 2007 Sep; 36(9 Pt 2):1271-7. PubMed ID: 17521857
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Diagnosis and treatment of genetic haemochromatosis].
    Milman NT
    Ugeskr Laeger; 2013 Apr; 175(16):1109-12. PubMed ID: 23651749
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunohistochemistry of the Hfe protein in patients with hereditary hemochromatosis, iron deficiency anemia, and normal controls.
    Byrnes V; Ryan E; O'Keane C; Crowe J
    Blood Cells Mol Dis; 2000 Feb; 26(1):2-8. PubMed ID: 10772870
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distinct requirements for Hfe in basal and induced hepcidin levels in iron overload and inflammation.
    Constante M; Jiang W; Wang D; Raymond VA; Bilodeau M; Santos MM
    Am J Physiol Gastrointest Liver Physiol; 2006 Aug; 291(2):G229-37. PubMed ID: 16565419
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Knockdown of beta2-microglobulin perturbs the subcellular distribution of HFE and hepcidin.
    Bhatt L; Horgan CP; McCaffrey MW
    Biochem Biophys Res Commun; 2009 Jan; 378(4):727-31. PubMed ID: 19059216
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HJV and HFE Play Distinct Roles in Regulating Hepcidin.
    Wu Q; Wang H; An P; Tao Y; Deng J; Zhang Z; Shen Y; Chen C; Min J; Wang F
    Antioxid Redox Signal; 2015 May; 22(15):1325-36. PubMed ID: 25608116
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [HFE hemochromatosis: pathogenic and diagnostic approach].
    Brissot P; Le Lan C; Troadec MB; Lorho R; Ropert M; Lescoat G; Loréal O
    Transfus Clin Biol; 2005 Jun; 12(2):77-82. PubMed ID: 15925529
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum hepcidin levels are innately low in HFE-related haemochromatosis but differ between C282Y-homozygotes with elevated and normal ferritin levels.
    van Dijk BA; Laarakkers CM; Klaver SM; Jacobs EM; van Tits LJ; Janssen MC; Swinkels DW
    Br J Haematol; 2008 Sep; 142(6):979-85. PubMed ID: 18557745
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum prohepcidin concentration: no association with iron absorption in healthy men; and no relationship with iron status in men carrying HFE mutations, hereditary haemochromatosis patients undergoing phlebotomy treatment, or pregnant women.
    Roe MA; Spinks C; Heath AL; Harvey LJ; Foxall R; Wimperis J; Wolf C; Fairweather-Tait SJ
    Br J Nutr; 2007 Mar; 97(3):544-9. PubMed ID: 17313717
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factors influencing disease phenotype and penetrance in HFE haemochromatosis.
    Rochette J; Le Gac G; Lassoued K; Férec C; Robson KJ
    Hum Genet; 2010 Sep; 128(3):233-48. PubMed ID: 20607553
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of HFE in iron metabolism, hereditary haemochromatosis, anaemia of chronic disease, and secondary iron overload.
    Townsend A; Drakesmith H
    Lancet; 2002 Mar; 359(9308):786-90. PubMed ID: 11888608
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetics, Genetic Testing, and Management of Hemochromatosis: 15 Years Since Hepcidin.
    Pietrangelo A
    Gastroenterology; 2015 Oct; 149(5):1240-1251.e4. PubMed ID: 26164493
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bone morphogenetic protein signaling is impaired in an HFE knockout mouse model of hemochromatosis.
    Corradini E; Garuti C; Montosi G; Ventura P; Andriopoulos B; Lin HY; Pietrangelo A; Babitt JL
    Gastroenterology; 2009 Oct; 137(4):1489-97. PubMed ID: 19591830
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blunted hepcidin response to oral iron challenge in HFE-related hemochromatosis.
    Piperno A; Girelli D; Nemeth E; Trombini P; Bozzini C; Poggiali E; Phung Y; Ganz T; Camaschella C
    Blood; 2007 Dec; 110(12):4096-100. PubMed ID: 17724144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.